Nephros Inc Market Cap ($35.18 Million)
Market Cap & Net Worth: Nephros Inc (NEPH)
Nephros Inc market cap. Nephros Inc (NASDAQ:NEPH) has a market capitalization of $35.18 Million ($35.18 Million) as of November 4, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #22992 globally and #5044 in its home market, demonstrating a -10.74% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Nephros Inc's stock price $3.24 by its total outstanding shares 10856546 (10.86 Million). Also see cash efficiency ratio of Nephros Inc for how efficiently the company converts equity into cash flow.
Nephros Inc Market Cap History (2015–2026)
Nephros Inc market cap history from 2015 to 2026. Data shows change from $21.05 Million to $35.18 Million (-0.25% CAGR). Check Nephros Inc stock price for real-time trading data and today's change.
Index Memberships
Nephros Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.61 Trillion | 0.00% | #651 of 976 |
|
NASDAQ Composite
IXIC
|
$40.20 Trillion | 0.00% | #2156 of 3165 |
Weight: Nephros Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Nephros Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Nephros Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore net asset growth rate of Nephros Inc to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
2.82x
Nephros Inc's market cap is 2.82 times its annual revenue
Latest Price to Earnings (P/E) Ratio
44.37x
Nephros Inc's market cap is 44.37 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $35.77 Million | $2.32 Million | -$3.03 Million | 15.42x | N/A |
| 2017 | $43.98 Million | $3.81 Million | -$809.00K | 11.55x | N/A |
| 2018 | $55.69 Million | $5.69 Million | -$3.40 Million | 9.79x | N/A |
| 2019 | $108.02 Million | $10.33 Million | -$3.42 Million | 10.45x | N/A |
| 2020 | $93.15 Million | $8.56 Million | -$4.77 Million | 10.88x | N/A |
| 2021 | $64.05 Million | $10.22 Million | -$4.11 Million | 6.27x | N/A |
| 2022 | $12.56 Million | $9.97 Million | -$7.38 Million | 1.26x | N/A |
| 2023 | $37.56 Million | $14.24 Million | -$1.57 Million | 2.64x | N/A |
| 2024 | $15.96 Million | $14.16 Million | $74.00K | 1.13x | 215.66x |
| 2025 | $52.98 Million | $18.79 Million | $1.19 Million | 2.82x | 44.37x |
Competitor Companies of NEPH by Market Capitalization
Companies near Nephros Inc in the global market cap rankings as of November 4, 2026. Also see how large is Nephros Inc's balance sheet for a full breakdown of the balance sheet.
Key companies related to Nephros Inc by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #175 globally with a market cap of $132.26 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #258 globally with a market cap of $99.74 Billion USD ( €85.32 Billion EUR).
- ESSILORLUXOTTICA 1/2/O.N. (F:ESLC): Ranked #418 globally with a market cap of $67.43 Billion USD ( €57.68 Billion EUR).
- HOYA CORP. ADR/ 1 O.N. (F:HYB0): Ranked #535 globally with a market cap of $50.37 Billion USD ( €43.09 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #175 | Intuitive Surgical Inc | NASDAQ:ISRG | $132.26 Billion | $440.75 |
| #258 | EssilorLuxottica S. A. | PA:EL | $99.74 Billion | €184.25 |
| #418 | ESSILORLUXOTTICA 1/2/O.N. | F:ESLC | $67.43 Billion | €91.50 |
| #535 | HOYA CORP. ADR/ 1 O.N. | F:HYB0 | $50.37 Billion | €150.00 |
Market Capitalization of Nephros Inc (2015–2026)
Market capitalization of Nephros Inc from 2015 to today. Between 2015 and today, Nephros Inc's market cap moved from $21.05 Million to $ 35.18 Million, with a yearly change of -0.25%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $35.18 Million | -33.61% |
| 2025 | $52.98 Million | +231.97% |
| 2024 | $15.96 Million | -57.51% |
| 2023 | $37.56 Million | +199.00% |
| 2022 | $12.56 Million | -80.39% |
| 2021 | $64.05 Million | -31.24% |
| 2020 | $93.15 Million | -13.77% |
| 2019 | $108.02 Million | +93.96% |
| 2018 | $55.69 Million | +26.64% |
| 2017 | $43.98 Million | +22.94% |
| 2016 | $35.77 Million | +69.93% |
| 2015 | $21.05 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Nephros Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $35.18 Million USD |
| MoneyControl | $35.18 Million USD |
| MarketWatch | $35.18 Million USD |
| marketcap.company | $35.18 Million USD |
| Reuters | $35.18 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Nephros Inc
Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella a… Read more